Jump to main content
Jump to site search

Issue 6, 2013
Previous Article Next Article

Biomaterial approaches to gene therapies for neurodegenerative disorders of the CNS

Author affiliations

Abstract

Neurodegeneration gives rise to a wide range of disorders which represent a growing health burden to both western societies and developing countries. Whilst for many disorders such as Alzheimer's and Parkinson's disease the cause is unknown, gene therapy is becoming the forefront of novel potential therapies described in the literature and has entered clinical trials. Furthermore, although in somewhat an earlier stage, biomaterials offer means of enhancing gene therapy strategies either through new delivery methods or provision of support for genetically manipulated cells. This review outlines recent uses of biomaterials in the CNS and captures recent advances in non-viral gene delivery to the brain. Three dimensional scaffolding systems for ex vivo gene delivery to the brain are also discussed highlighting the progress of hydrogel mediated cell delivery. This review also addresses the difficulties and safety considerations of these approaches; illustrating the ability of biomaterial strategies to significantly improve outcomes of gene therapies for neurodegenerative disorders.

Graphical abstract: Biomaterial approaches to gene therapies for neurodegenerative disorders of the CNS

Back to tab navigation

Publication details

The article was received on 01 Feb 2013, accepted on 19 Mar 2013 and first published on 05 Apr 2013


Article type: Review Article
DOI: 10.1039/C3BM60030K
Citation: Biomater. Sci., 2013,1, 556-576
  •   Request permissions

    Biomaterial approaches to gene therapies for neurodegenerative disorders of the CNS

    B. Newland, E. Dowd and A. Pandit, Biomater. Sci., 2013, 1, 556
    DOI: 10.1039/C3BM60030K

Search articles by author

Spotlight

Advertisements